Effectiveness of immune checkpoint inhibitors in the treatment of kidney cancer oral metastasis. A case report
Authors:
- 7 May 2024
- journal article
- editorial
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 125 (5) , 101913
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell CarcinomaEuropean Urology, 2022
- Metastatic Tumors to the Oral Soft Tissues and Jawbones: A Retrospective Analysis of 40 Cases and Review of the LiteratureHead and Neck Pathology, 2022
- Revisiting the Vertebral Venous Plexus–A Comprehensive Review of the LiteratureWorld Neurosurgery, 2021
- Renal Cell Carcinoma Metastases to the Oral Cavity: Report of 2 Cases and Review of LiteratureJournal of Oral and Maxillofacial Surgery, 2020
- Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trialThe Lancet Oncology, 2019
- Metastatic Clear-cell Renal Cell Carcinoma With a Long-term Response to Sunitinib: A Distinct Phenotype Independently Associated With Low PD-L1 ExpressionClinical Genitourinary Cancer, 2019
- Metastasis in renal cell carcinoma: Biology and implications for therapyAsian Journal of Urology, 2016
- Metastatic Clear Cell Renal Carcinoma of the Palate Mimicking Noninvoluting Congenital HemangiomaJournal of Oral and Maxillofacial Surgery, 2011
- Metastatic tumours to the oral cavity – Pathogenesis and analysis of 673 casesOral Oncology, 2008
- Management of solitary palatal metastasis from renal cell carcinomaNature Reviews Endocrinology, 2006